• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer
2024 AUA Recaps : Episode 2

AUA 2024: Dr. Zorn recaps key BPH research


In this video, Kevin C. Zorn, MD, FRCSC, FACS, discusses key BPH data from the 2024 American Urological Association Annual Meeting.

In this video, Kevin C. Zorn, MD, FRCSC, FACS, recaps data in benign prostatic hyperplasia (BPH) that was presented at the 2024 American Urological Association Annual Meeting in San Antonio, Texas. Zorn is the founder and director of BPH Canada in Montreal.

The following research is discussed:

1. P2-13: Preliminary RCT Analysis of Minimally Invasive Surgery vs. Medication in the Initial Treatment of BPH-Associated LUTS

2. MP27-04: Multi-center report on acute clinical outcomes with Rivermark FloStent™

3. MP20-02: Aquablation at 4-years: the largest, real world, single-center study and longest follow-up data for this innovative BPH treatment

4. MP46-03: Preservation of Sexual Function with Optilume: A Novel Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

5. MP20-05: Day Case Aquablation: First Published Experience Report in Ambulatory Surgical Center (ASC)

Related Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Gamal M. Ghoniem, MD, FACS, ABU/FPMRS, gives an answer during a video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Zhina Sadeghi, MD, answers a question during a video interview
Stephanie Gleicher, MD, answers a question during a Zoom video interview
Human kidney cross section on scientific background | © Crystal light - stock.adobe.com
Mature woman with her doctor | Image Credit: © pucko_ns - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.